ArticleCureus2024
Ocular Metastatic Tumor in a Patient With Hepatocellular Carcinoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While orbital floor metastasis from hepatocellular carcinoma (HCC) has been reported, ocular (eyeball) metastasis is exceedingly rare. Most ocular metastases originate from breast or lung cancer. In this article, we present the case of a 65-year-old man diagnosed with HCC with central necrosis (cT3N0M0, stage III) based on characteristic imaging findings. As liver resection was not indicated, biliary drainage, ascites control, and transcatheter arterial chemoembolization (TACE) were performed. On day 62 of admission, he developed right-sided visual disturbance accompanied by severe pain. A fundus examination and head CT scan by an ophthalmologist indicated a tumor in the right eye. A whole-body CT scan was performed again, revealing no other distant metastases apart from the eye. Based on the clinical course, ocular metastasis from HCC was diagnosed. Due to poor general condition, enucleation was not performed. Pain management with medication alone was insufficient, but two sessions of radiation therapy significantly alleviated the pain. Prompt treatment is crucial as ocular metastasis is associated with pain and vision impairment, significantly affecting the patient's quality of life. When systemic treatment is not feasible, local treatment options, such as radiation therapy, become important. Radiation therapy for ocular metastases is valuable, as it can provide rapid symptomatic relief.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.